<DOC>
	<DOCNO>NCT02264158</DOCNO>
	<brief_summary>Assessment influence telmisartan , lacidipine combination QTC interval ECG</brief_summary>
	<brief_title>Influence Telmisartan Lacidipine , Combined Alone , QT Interval Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Lacidipine</mesh_term>
	<criteria>All participant study healthy males/females , range 21 50 year age body mass index ( BMI ) within 18.5 29.9 kg/m2 . In accordance Good Clinical Practice local legislation volunteer give write informed consent prior admission study . Any finding medical examination ( include blood pressure , heart rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug enrolment study study Use drug might influence result trial 7 day prior enrolment study study Participation another tiral investigational drug ( &lt; = two month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( &gt; = 100 ml within four week prior administration trial ) Any laboratory value outside clinically accept reference range Excessive physical activity within last week trial trial Following exclusion criterion special interest study : Hypersensitivity telmisartan , lacidipine and/or relate drug class Supine blood pressure screen systolic &lt; = 110 mmHg diastolic &lt; = 60 mmHg Any ECG value outside reference range clinical relevance , limited PR interval &gt; 240 m , QRS interval &gt; 110 m , QTcB &gt; 470 m female QTcB &gt; 450 m male For female subject : Pregnancy Positive pregnancy test No adequate contraception ( adequate contraception e.g . sterilisation , intrauterine pessary ( IUP ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>